437.44MMarket Cap-2171P/E (TTM)
4.170High3.840Low1.98MVolume3.860Open3.920Pre Close8.03MTurnover2.06%Turnover RatioLossP/E (Static)104.90MShares9.74552wk High-2.68P/B402.17MFloat Cap2.30052wk Low--Dividend TTM96.44MShs Float42.410Historical High--Div YieldTTM8.42%Amplitude2.300Historical Low4.051Avg Price1Lot Size
Revance Therapeutics Stock Forum
📊⚡️📊
📊⚡️📊
On October 24, 2024, Revance Therapeutics, Inc. (the “Company”) and Teoxane SA (“Teoxane”), entered into the Sixth Amendment to the Exclusive Distribution Agreement (the “Sixth Amendment”). As previously disclosed on a Current Report on Form 8-K filed on January 10, 2020, the Company entered into the Exclusive Distribution Agreement with Teoxane on January 10, 2020 (the “Distribution Agreement”), pursuant to which Teoxane granted the Company with the exclus...
🟢 Recently Announced:
⇒ $Organon & Co (OGN.US)$ to acquire Dermavant
⇒ $Rafael Holdings (RFL.US)$ to acquire Cyclo Tx
⇒Crown Lab to acquire $Revance Therapeutics (RVNC.US)$
⇒ $Recursion Pharmaceuticals (RXRX.US)$ merger with Exscientia
🔴 Recently Closed:
⇒ $Johnson & Johnson (JNJ.US)$ acquired V-Wave
⇒ Pharmacosmos acquired $GTHX
What companies will be next? 🤔
No comment yet